Trethera Announces Inflammatory Bowel Disease Poster Presentation at the Annual Crohn's ...
The story describes a new drug mechanism (dCK inhibition) that reduced inflammation in an IBD mouse model, which could point to a different way to target overactive immune cells in Crohn’s disease. It’s early-stage...